Drawing for SAYIYAS

USPTO serial 88269384

SAYIYAS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
FRENCH, CURTIS W
Law office
TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with SAYIYAS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James Urzedowski

James Urzedowski Forsgren Fisher McCalmont DeMarea Tysver LLP225 SOUTH 6TH STREETSUITE 1750MINNEAPOLIS, MN 55402

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for human or animal use, namely, pharmaceuticals for the treatment of neurological disease, pharmaceuticals for the treatment of cardiovascular diseases, pharmaceuticals for the treatment of ischemia, pharmaceuticals for the treatment of stroke, pharmaceuticals for the treatment of neuronal injury, and pharmaceuticals for the treatment of neurodegenerative diseasesACTIVE—
041Educational services, namely, conducting conferences, seminars, webinars, video case studies, classes and workshops in the fields of healthcare, pharmaceuticals and medicine, pharmaceutical research and developmentACTIVE—
044Providing a website featuring medical and health information; providing a website featuring medical and health information in the field of the prophylactic and therapeutic properties of pharmaceuticals; providing health information; providing patients with health and medical information; counseling and charitable services for patients, namely, providing medical and health information and health informational assistance with respect to obtaining prescription medicationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Oct 29, 2021MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 29, 2021MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 29, 2021ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 14, 2021GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Apr 14, 2021GNSIINQUIRY TO SUSPENSION E-MAILED—
Apr 14, 2021CNSISUSPENSION INQUIRY WRITTEN—
Mar 26, 2021RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jan 12, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 12, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 12, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 18, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Sep 18, 2020GNSLLETTER OF SUSPENSION E-MAILED—
Sep 18, 2020CNSLSUSPENSION LETTER WRITTEN—
Sep 15, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 15, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 9, 2020ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Mar 24, 2020GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Mar 24, 2020GNSIINQUIRY TO SUSPENSION E-MAILED—
Mar 24, 2020CNSISUSPENSION INQUIRY WRITTEN—
Mar 9, 2020RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Aug 16, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Aug 16, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Aug 16, 2019CNSLSUSPENSION LETTER WRITTEN—
Aug 16, 2019ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Aug 13, 2019OTHECASE RETURNED TO EXAMINATION—
Aug 13, 2019IUCNNOTICE OF ALLOWANCE CANCELLED—
Aug 13, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 18, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 18, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 7, 2019CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 7, 2019COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 29, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 10, 2019FIXDELECTRONIC RECORD REVIEW COMPLETE—
May 3, 2019ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Apr 25, 2019ALIEASSIGNED TO LIE—
Apr 11, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 2, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Apr 2, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 2, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 2, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 2, 2019DOCKASSIGNED TO EXAMINER—
Feb 12, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 4, 2019TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Feb 4, 2019PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jan 24, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance